Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
- PMID: 21703178
- DOI: 10.1016/j.jhep.2011.03.020
Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
Abstract
Background & aims: Non-alcoholic fatty liver disease (NAFLD) is a common cause of abnormal LFTs in primary care, but there are no data defining its contribution nor reporting the range of NAFLD severity in this setting. This study seeks to calculate the range of disease severity of NAFLD in a primary care setting.
Methods: Adult patients with incidental abnormal LFTs, in the absence of a previous history, or current symptoms/signs of liver disease were prospectively recruited from eight primary care practices in Birmingham. NAFLD was diagnosed as fatty liver on ultrasound, negative serological liver aetiology screen, and alcohol consumption ≤30 and ≤20 g/day in males and females, respectively. The NAFLD Fibrosis Score (NFS) was calculated to determine the presence or absence of advanced liver fibrosis in subjects identified with NAFLD.
Results: Data from 1118 adult patients were analysed. The cause of abnormal LFTs was identified in 55% (614/1118) of subjects, with NAFLD (26.4%; 295/1118) and alcohol excess (25.3%; 282/1118) accounting for the majority. A high NFS (>0.676) suggesting the presence of advanced liver fibrosis was found in 7.6% of NAFLD subjects, whereas 57.2% of NAFLD patients had a low NFS (<-1.455) allowing advanced fibrosis to be confidently excluded.
Conclusions: NAFLD is the commonest cause of incidental LFT abnormalities in primary care (26.4%), of whom 7.6% have advanced fibrosis as calculated by the NFS. This study is the first of its kind to highlight the burden of NAFLD in primary care and provide data on disease severity in this setting.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Comment in
-
Touching some firm ground in the epidemiology of NASH.J Hepatol. 2012 Jan;56(1):23-5. doi: 10.1016/j.jhep.2011.08.002. Epub 2011 Aug 27. J Hepatol. 2012. PMID: 21875499 No abstract available.
Similar articles
-
NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.World J Gastroenterol. 2013 Feb 28;19(8):1219-29. doi: 10.3748/wjg.v19.i8.1219. World J Gastroenterol. 2013. PMID: 23482703 Free PMC article.
-
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.Hepatology. 2013 Apr;57(4):1357-65. doi: 10.1002/hep.26156. Epub 2013 Jan 25. Hepatology. 2013. PMID: 23175136 Free PMC article.
-
Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease.J Dig Dis. 2012 Nov;13(11):588-95. doi: 10.1111/j.1751-2980.2012.00631.x. J Dig Dis. 2012. PMID: 23107446 Clinical Trial.
-
High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.Ann Med. 2021 Dec;53(1):1621-1631. doi: 10.1080/07853890.2021.1974081. Ann Med. 2021. PMID: 34498502 Free PMC article.
-
Identification of liver disease: why and how.Frontline Gastroenterol. 2022 Jan 24;13(5):367-373. doi: 10.1136/flgastro-2021-101833. eCollection 2022. Frontline Gastroenterol. 2022. PMID: 36051960 Free PMC article. Review.
Cited by
-
Does Nonalcoholic Fatty Liver Disease Increase the Risk for Extrahepatic Malignancies?Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):215-219. doi: 10.1002/cld.1029. eCollection 2021 Mar. Clin Liver Dis (Hoboken). 2021. PMID: 33868668 Free PMC article. Review. No abstract available.
-
Writing liver function test guidelines: how hard can it be?Br J Gen Pract. 2016 Aug;66(649):426. doi: 10.3399/bjgp16X686353. Br J Gen Pract. 2016. PMID: 27481972 Free PMC article. No abstract available.
-
Correlation of Serum Transaminase Levels with Liver Fibrosis Assessed by Transient Elastography in Vietnamese Patients with Nonalcoholic Fatty Liver Disease.Int J Gen Med. 2021 Apr 16;14:1349-1355. doi: 10.2147/IJGM.S309311. eCollection 2021. Int J Gen Med. 2021. PMID: 33889015 Free PMC article.
-
A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At-Risk Populations in Primary Care.Hepatol Commun. 2018 Aug 6;2(8):893-905. doi: 10.1002/hep4.1208. eCollection 2018 Aug. Hepatol Commun. 2018. PMID: 30094401 Free PMC article.
-
Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions.World J Clin Cases. 2018 Dec 6;6(15):922-930. doi: 10.12998/wjcc.v6.i15.922. World J Clin Cases. 2018. PMID: 30568947 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources